A detailed history of Israel Englander (Millennium Management LLC) transactions in Milestone Pharmaceuticals Inc. stock. As of the latest transaction made, Millennium Management LLC holds 2,778,525 shares of MIST stock, worth $5.17 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,778,525
Previous 2,749,930 1.04%
Holding current value
$5.17 Million
Previous $3.63 Million 16.37%
% of portfolio
0.0%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$1.29 - $1.65 $36,887 - $47,181
28,595 Added 1.04%
2,778,525 $4.22 Million
Q2 2024

Aug 14, 2024

SELL
$1.29 - $1.83 $136,329 - $193,398
-105,682 Reduced 3.7%
2,749,930 $3.63 Million
Q1 2024

May 15, 2024

BUY
$1.4 - $2.2 $1.91 Million - $2.99 Million
1,361,123 Added 91.08%
2,855,612 $5.11 Million
Q4 2023

Feb 14, 2024

SELL
$1.67 - $3.39 $428,653 - $870,141
-256,679 Reduced 14.66%
1,494,489 $2.5 Million
Q2 2023

Aug 14, 2023

BUY
$2.85 - $4.4 $63,116 - $97,442
22,146 Added 1.28%
1,751,168 $4.99 Million
Q1 2023

May 15, 2023

SELL
$3.14 - $4.2 $835,261 - $1.12 Million
-266,007 Reduced 13.33%
1,729,022 $6.81 Million
Q4 2022

Feb 14, 2023

BUY
$3.53 - $9.5 $3.75 Million - $10.1 Million
1,061,931 Added 113.81%
1,995,029 $7.9 Million
Q3 2022

Nov 14, 2022

SELL
$5.86 - $9.43 $2.49 Million - $4.01 Million
-425,264 Reduced 31.31%
933,098 $8.58 Million
Q2 2022

Aug 15, 2022

BUY
$5.13 - $7.37 $356,222 - $511,765
69,439 Added 5.39%
1,358,362 $8.07 Million
Q1 2022

May 16, 2022

BUY
$4.1 - $8.24 $1.24 Million - $2.5 Million
303,056 Added 30.74%
1,288,923 $8.28 Million
Q4 2021

Feb 14, 2022

BUY
$5.47 - $7.13 $1.59 Million - $2.07 Million
290,626 Added 41.8%
985,867 $6.46 Million
Q3 2021

Nov 15, 2021

SELL
$5.28 - $6.29 $123,493 - $147,116
-23,389 Reduced 3.25%
695,241 $3.97 Million
Q2 2021

Aug 16, 2021

BUY
$5.22 - $6.11 $4,348 - $5,089
833 Added 0.12%
718,630 $3.95 Million
Q1 2021

May 17, 2021

BUY
$5.79 - $8.85 $11,643 - $17,797
2,011 Added 0.28%
717,797 $4.16 Million
Q4 2020

Feb 16, 2021

BUY
$5.57 - $7.66 $2.27 Million - $3.13 Million
408,032 Added 132.58%
715,786 $4.8 Million
Q3 2020

Nov 16, 2020

BUY
$3.34 - $9.8 $1.03 Million - $3.02 Million
307,754 New
307,754 $2.25 Million
Q2 2020

Aug 14, 2020

SELL
$1.77 - $4.56 $339,588 - $874,872
-191,858 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$1.7 - $22.5 $276,018 - $3.65 Million
162,364 Added 550.5%
191,858 $353,000
Q4 2019

Feb 14, 2020

BUY
$15.4 - $21.9 $89,166 - $126,800
5,790 Added 24.43%
29,494 $472,000
Q3 2019

Nov 14, 2019

SELL
$15.67 - $25.96 $164,456 - $272,450
-10,495 Reduced 30.69%
23,704 $410,000
Q2 2019

Aug 15, 2019

BUY
$15.37 - $27.15 $318,927 - $563,362
20,750 Added 154.29%
34,199 $929,000
Q2 2019

Aug 14, 2019

BUY
$15.37 - $27.15 $206,711 - $365,140
13,449 New
13,449 $292,000

Others Institutions Holding MIST

About Milestone Pharmaceuticals Inc.


  • Ticker MIST
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,010,900
  • Market Cap $55.8M
  • Description
  • Milestone Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of cardiovascular medicines. The company is developing etripamil, a novel channel blocker, which is in Phase III clinical trial for the treatment of paroxysmal supraventricular tachycardia in the United States and Canada; and Phase II cl...
More about MIST
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.